Updated 1h ago

generalnews.media

AI reads 36 sources every 2 hours and ranks each story by importance from 1 to 5 - so you see what actually matters.

Showing 500 most recent of 2136 stories
Exclusive

Should children avoid sugar during their first 1,000 days?

New Scientist examines whether children should be kept away from sugar during their first 1,000 days, from conception to age two. This period is considered critical for lifelong health, and early sugar exposure may shape taste preferences and obesity risk. The question matters because infant and toddler dietary advice can have long-term health consequences.

science technology

Big Tech Is Building an AI-Era Military-Industrial Complex

Nature examines how major technology companies are deepening ties with militaries, creating a new military-industrial complex shaped by artificial intelligence. The trend raises concerns about corporate power, arms races, and the governance of AI in warfare.

Exclusive

Nobel medicine prize called overdue, prompting "what took them so long?"

A Nature commentary argues this year's Nobel Prize in Physiology or Medicine went to work that had long deserved recognition, with observers asking why the award took so long. The piece highlights how major science prizes can lag well behind the discoveries they honor.

science

AI biohazard hype must not distract from today's real biological risks

A Nature commentary argues that speculation about AI-enabled bioweapons and lab-made pandemics is drawing attention and funding away from biological threats that already exist, such as natural outbreaks, laboratory accidents and gaps in global biosurveillance. The authors warn that overhyping future AI scenarios can distort policy priorities and fuel counterproductive restrictions on legitimate research. They call for keeping near-term, well-documented risks at the centre of biosecurity planning.

Exclusive

Cancer's biggest wins of the past 50 years, measured by the numbers

Nature has published a data-driven retrospective tallying the most significant advances in cancer research and treatment over the past half-century. The analysis quantifies gains including falling overall death rates, sharp survival improvements in childhood leukemia, and the rise of targeted therapies and immunotherapy. It matters because the figures show where decades of funding and research have paid off, and where progress has lagged.